相关实验视频
Updated: Jun 8, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
792
罕见出血疾病的历史
Akbar Dorgalaleh1, Behnaz Tavasoli2, Saeed Hassani3
1Hamin Pazhuhan Tis Institute, Tehran, Iran.
Seminars in thrombosis and hemostasis
|November 4, 2024
概括
罕见的出血障碍 (RBDs) 涉及纤维素和前素等凝固因子的缺陷. 虽然治疗方法已经从输血发展到因子缩剂,但为了更好的诊断和护理,需要进一步的研究.
科学领域:
- 血液学 血液学 血液学
- 罕见疾病 罕见疾病
- 凝血障碍 凝血障碍 凝血障碍
背景情况:
- 罕见的出血障碍包括I (FI),II (FII),V (FV),FV和FVIII (CF5F8) 结合的凝血因子以及维生素K依赖因子 (FVII,FX,FXI,FXIII) 的缺陷.
- 这些因素的历史识别范围从1859年 (纤维素) 到1956年 (FX),第一个被诊断为RBD患者是在1920年,最新的是在1966年.
研究的目的:
- 审查历史背景,诊断进化和罕见出血障碍的治疗进展.
- 突出目前治疗的局限性和进一步研究的需要.
主要方法:
- 关于凝血因子识别和罕见出血障碍诊断的历史文献综述.
- 对从全血输血到现代因子缩剂和重组疗法等治疗干预措施的分析.
主要成果:
- 凝血因子缩剂可用于FI,FVII,FX,FXI和FXIII,并为FVII和FXIII提供重组选项.
- 新鲜冷血 (FFP) 和/或血小板输血仍然是FV缺乏的主要治疗方法.
- 在诊断和管理方面取得了显著的进步,但仍然存在挑战.
结论:
- 尽管治疗方面取得了进展,特别是使用因子缩剂,但FV缺乏症治疗仍然有限.
- 持续的研究对于解决罕见出血障碍的诊断和治疗挑战至关重要.
- 改善理解和管理将提高受影响个人的生活质量.
更多相关视频
相关概念视频
Disorders of Hemostasis
716
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
716
Blood Transfusion and Agglutination
10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K
Esophageal Varices-II: Clinical Features and Management
46
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
46
Disorders of Erythrocytes
873
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
873
Esophageal Varices-I: Introduction
76
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
76
Anticoagulant Drugs: Low-Molecular-Weight Heparins
624
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
624

